This company has been acquired
Yourgene Health Management
Management criteria checks 3/4
Yourgene Health's CEO is Lyn Rees, appointed in Jul 2018, has a tenure of 5.17 years. total yearly compensation is £394.00K, comprised of 67.5% salary and 32.5% bonuses, including company stock and options. directly owns 2.67% of the company’s shares, worth $553.14K. The average tenure of the management team and the board of directors is 2.8 years and 4.1 years respectively.
Key information
Lyn Rees
Chief executive officer
UK£394.0k
Total compensation
| CEO salary percentage | 67.5% |
| CEO tenure | 5.2yrs |
| CEO ownership | 2.7% |
| Management average tenure | 2.8yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -UK£8m |
| Jun 30 2022 | n/a | n/a | -UK£5m |
| Mar 31 2022 | UK£394k | UK£266k | -UK£2m |
| Dec 31 2021 | n/a | n/a | -UK£6m |
| Sep 30 2021 | n/a | n/a | -UK£10m |
| Jun 30 2021 | n/a | n/a | -UK£11m |
| Mar 31 2021 | UK£299k | UK£238k | -UK£12m |
| Dec 31 2020 | n/a | n/a | -UK£8m |
| Sep 30 2020 | n/a | n/a | -UK£4m |
| Jun 30 2020 | n/a | n/a | -UK£3m |
| Mar 31 2020 | UK£220k | UK£190k | -UK£2m |
| Dec 31 2019 | n/a | n/a | UK£1m |
| Sep 30 2019 | n/a | n/a | UK£5m |
| Jun 30 2019 | n/a | n/a | UK£4m |
| Mar 31 2019 | UK£203k | UK£122k | UK£3m |
Compensation vs Market: Lyn's total compensation ($USD495.69K) is below average for companies of similar size in the US market ($USD754.13K).
Compensation vs Earnings: Lyn's compensation has increased whilst the company is unprofitable.
CEO
Lyn Rees (49 yo)
5.2yrs
Tenure
UK£394,000
Compensation
Mr. Lyn Dafydd Rees serves as Non-Executive Director at MyHealthChecked Plc (formerly known as Concepta PLC) since November 2019. Mr. Rees serves as Chief Executive Officer and Director at Yourgene Health...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.2yrs | UK£394.00k | 2.67% $ 553.1k | |
| Chief Scientific Officer | 2.8yrs | UK£192.00k | 0.22% $ 45.4k | |
| Chief Entrepreneur & Director | 2.8yrs | UK£123.00k | 9.89% $ 2.0m | |
| Interim Chief Financial Officer | less than a year | no data | no data | |
| Vice President of Global Operations | no data | no data | no data | |
| Director of Marketing | 8.5yrs | no data | no data | |
| HR Director | no data | no data | no data |
2.8yrs
Average Tenure
48yo
Average Age
Experienced Management: VILG.F's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.2yrs | UK£394.00k | 2.67% $ 553.1k | |
| Chief Entrepreneur & Director | no data | UK£123.00k | 9.89% $ 2.0m | |
| Senior Independent Non-Executive Chairman | 4.2yrs | UK£40.00k | 1.05% $ 218.3k | |
| Non-Executive Director | 1.7yrs | UK£7.00k | no data | |
| Non-Executive Director | 4.1yrs | UK£30.00k | no data | |
| Non-Executive Director | less than a year | no data | no data |
4.1yrs
Average Tenure
56.5yo
Average Age
Experienced Board: VILG.F's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/09/05 10:36 |
| End of Day Share Price | 2023/06/09 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2022/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yourgene Health Plc is covered by 6 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Cavendish |
| Mark Brewer | Cavendish |
| Martin Hall | Hardman & Co. |